U.S. prescription drug sales climbed by 5.1 percent to $300.3 billion in 2009, easily outpacing the 1.8 percent growth rate seen in 2008, according to data collected by IMS Health. While the growth rate was far stronger than that seen the previous two years, it still represents historically low levels, said IMS, a leading provider [...]
Continue reading...Saturday, March 13, 2010
The anti-clotting drug Plavix must now carry a “black box” warning on its label, alerting patients and doctors that some people don’t metabolize the medication properly, U.S. health officials said Friday. Patients with a certain genetic variation can’t convert the blood thinner into its active form, which puts them at risk for heart attack and [...]
Continue reading...
Friday, April 2, 2010
0 Comments